West London company Sauflon Pharmaceuticals makes contact lenses and aftercare products. It has benefited from growing demand for disposable products. The company is led by joint managing directors, David Wells, 49, and Bradley Wells, 43, sons of one of the company’s co-founders. Hollyport Capital and Bond Capital Partners have a 44% stake. Profits reached £13.5m in 2012 and, after our research closed, Sauflon reported that profits rose 33% to £17.9m in 2013.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.